CD, D., MJ, T., T, W., RC, B., P, D., F, E. R., . . . KL, H. (2023). A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis. Blood, 141(2), 168. https://doi.org/10.1182/blood.2022015797
Chicago Style (17th ed.) CitationCD, Dampier, et al. "A Randomized Clinical Trial of the Efficacy and Safety of Rivipansel for Sickle Cell Vaso-occlusive Crisis." Blood 141, no. 2 (2023): 168. https://doi.org/10.1182/blood.2022015797.
MLA (9th ed.) CitationCD, Dampier, et al. "A Randomized Clinical Trial of the Efficacy and Safety of Rivipansel for Sickle Cell Vaso-occlusive Crisis." Blood, vol. 141, no. 2, 2023, p. 168, https://doi.org/10.1182/blood.2022015797.
Warning: These citations may not always be 100% accurate.